Patents
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
08/2006
08/30/2006CN1272322C Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
08/30/2006CN1272316C Benzamides and related inhibitors of factor Xa
08/30/2006CN1272313C 20-hydroxyeicosatetraenoic acid production inhibitors
08/29/2006CA2212856C Benzopyran-containing compounds and method for their use
08/24/2006WO2006088193A1 Anti-tumor agent
08/24/2006WO2006052430A3 Opiate intermediates and methods of synthesis
08/24/2006US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
08/24/2006CA2599046A1 Antitumor agent
08/23/2006EP1693365A1 Inhibitors of dipeptidyl peptidase IV
08/23/2006EP1692112A1 Compounds, compositions, and methods
08/23/2006CN1822841A Anti-coronavirus drug
08/22/2006US7094909 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group
08/22/2006US7094895 Inotropic agents such as (S)-N-tert-butyloxycarbonyl-N-methyl-tyrosyl)-4-(4-nitrophenyl)-piperazine, used for preventing and/or prophylaxis of diseases associated with adenosine 5'-triphosphate
08/22/2006US7094807 Viricides; hepatitis virus
08/22/2006US7094789 5-substituted isoquinoline derivatives
08/17/2006WO2006085688A1 Psychogenic pain therapeutic agent
08/17/2006WO2006085108A1 Awthranilic acid derivatives and their use in treatment of diseases of lipid metabolism, in particular dyslipidaemia
08/17/2006WO2006026533A8 Methods of treatment of amyloidosis using ethanol cyclicamine derivatives aspartyl protease inhibitors
08/17/2006US20060183741 Treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome
08/16/2006EP1689719A1 7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (proteinkinase b)
08/16/2006EP1689718A1 1-amino-isoquinoline derivatives for the treatment of diseases associated with inappropriate alk5 activity
08/16/2006EP1689717A1 Substituted isoquinolines useful in the treatment of diseases such as cancer and atherosclerosis
08/16/2006EP1689716A1 Biaryl sulfonamides and methods for using same
08/16/2006EP1689701A1 Process of preparing o-carbamoyl compounds in the presence of active amine group
08/16/2006EP1689699A2 Anthranilic acid derivatives and their use as activators of the hm74a receptor
08/16/2006EP1689380A2 Method for treating adamts-5-associated disease
08/16/2006EP0861236B2 Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids
08/16/2006CN1819993A Intermediates useful in the synthesis of HIV-protease inhibitors and methods for preparing the same
08/16/2006CN1817864A Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
08/15/2006US7090931 Photoactive layer containing a lanthanide complex, in particular, lanthanide2(beta-enolate)6(pyridine-N-oxide)3; electronic devices in which the active layer includes a photoactive lanthanide complex
08/15/2006CA2245825C Process for the preparation and isolation of atracurium besylate
08/10/2006WO2006082768A1 Ionic organic compound
08/10/2006WO2006082354A1 Azacyclic compounds as inhibitors of sensory neurone specific channels ( sns )
08/10/2006US20060178515 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists
08/10/2006US20060178366 Compounds for the treatment of inflammatory disorders
08/10/2006US20060177694 Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency
08/09/2006EP1687299A1 Heterocyclic compounds as modulators of peroxisome proliferator activated receptors, useful for the treamtment and/or prevention of disorders modulated by a ppar
08/09/2006EP1687268A1 Benzylether amine compounds useful as ccr-5 antagonists
08/09/2006EP1686996A1 Quinazolinone compounds with reduced bioaccumulation
08/09/2006CN1816527A Nitrogen-containing heteroaryl compounds and their use in increasing endogenous erythropoietin
08/09/2006CN1816525A Metal complex compound and organic electroluminescence device containing the same
08/08/2006US7087323 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes
08/08/2006CA2200707C Novel prostaglandin synthase inhibitors
08/03/2006WO2006079467A1 Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
08/03/2006WO2006065479A3 Substituted phenols as active agents inhibiting vegf production
08/03/2006WO2005060456A8 Method for treating adamts-5-associate disease
08/03/2006US20060173044 Substituted propargylamines
08/03/2006US20060173039 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline
08/03/2006US20060172990 Antibacterial agents
08/03/2006CA2595605A1 Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
08/02/2006CN1812966A N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides
08/02/2006CN1812790A 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor
08/01/2006US7084158 Substituted propargylamines
08/01/2006US7084154 Reducing pain
07/2006
07/27/2006US20060167076 Acutumine and acutumine compounds synthesis and use
07/27/2006US20060166895 N-heterocyclic hydroxyethylamine compounds; human immunodeficiency virus (HIV) protease
07/26/2006EP1682537A1 Modulators of cellular adhesion
07/26/2006EP1682513A1 Method for producing cyclic, n-substituted alpha-iminocarboxylic acids
07/26/2006CN1266140C Process for preparing oxazolines from tetrahydrofurans
07/26/2006CN1266135C Method for preparing new demethyl conclaurine and medicinal salt
07/25/2006CA2395869C 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
07/20/2006WO2006074813A1 Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
07/20/2006WO2006026532A3 Methods of treatment of amyloidosis using substituted ethanolcyclicamine aspartyl protease inhibitors
07/20/2006WO2005121130A3 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
07/20/2006US20060160840 Tetrahydroisoquinolines as factor Xa inhibitors
07/20/2006CA2594419A1 Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
07/19/2006EP1680411A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
07/19/2006EP1680404A1 Process for producing dihydroisoquinoline zwitterions
07/19/2006EP1680109A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
07/19/2006EP1532124B1 Use of nitrile derivatives as medicament.
07/19/2006EP1451133A4 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
07/19/2006CN1805923A Benzamide derivative or salt thereof
07/19/2006CN1803797A Inhibitors of dipeptidyl peptidase IV
07/19/2006CN1803784A 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
07/18/2006USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals
07/18/2006US7078565 Benzamide derivatives as antagonists of orexin receptors
07/18/2006US7078552 Combretastatin A-1 phosphate and combretastatin B-1 phosphate prodrugs
07/18/2006US7078537 Phenylalkyl diamine and amide analogs
07/18/2006CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
07/13/2006US20060154988 intracellular inhibition of bacterial polypeptide deformylase in gramnegative bacteria,
07/13/2006US20060154872 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting
07/13/2006CA2593005A1 Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof
07/12/2006EP1679303A1 Process for preparing 1-alkoxycarbonyl-3-phenylpropyl derivative
07/12/2006EP1679296A1 Ether derivative
07/12/2006EP1678121A2 Tao kinase modulators and methods of use
07/12/2006EP1677745A2 Nitrone compounds prodrugs and pharmaceutical compositions of the same to treat human disorders
07/12/2006CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes.
07/12/2006CN1800164A Kukoline C ring modified derivative and its synthesis method
07/12/2006CN1264153C 光记录介质 The optical recording medium
07/11/2006US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders
07/11/2006US7074805 Especially isoquinolin-5-ylurea derivatives; treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.
07/11/2006US7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof
07/11/2006US7074796 High affinity for D4 receptors; treatment of psychological disorders such as schizophrenia, generalised anxiety disorder, panic disorder, and obsessive compulsive disorder.
07/11/2006US7074505 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes
07/11/2006US7074504 Photoactive layer containing a lanthanide complex selected from [Ln( beta -enolate)3] bisphosphine oxide-sulfide)1 and Ln( beta -enolate)3(bisphosphine oxide-sulfide)2 derivatives
07/11/2006CA2168447C Compounds and methods for inhibition of hiv and related viruses
07/11/2006CA2123731C Process for the preparation of carboxamides of nitrogen-containing aromatic heterocyclic compounds and their use
07/06/2006WO2006070878A1 Carboxylic acid derivative or salt thereof
07/06/2006US20060148815 4-Phenyl-1-piperazinyl, -piperidinyl and-tetrahydropyridyl derivatives
07/05/2006EP1676834A1 Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 119